The Prospective Study on the Effect of Ilaprazole in Non-erosive Reflux Disease Patients; Focused on Histologic Findings and Inflammatory Biomarker

NCT02666976 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Subepithelial Tumors

Interventions

DRUG: Ilaprazole

Sponsor

Yonsei University